Xolair 50242-0227
Generic: Omalizumab
Product NDC
50242-0227- Manufacturer
- Genentech, Inc.
- Dosage Form
- Injection, Solution
- Route
- Subcutaneous
- Product Type
- Human Prescription Drug
- Marketing Start
- August 18, 2023
- Listing Expires
- December 31, 2026
- Application
- BLA103976
Need to source Xolair? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Omalizumab | 300 mg/2mL |
Drug Class
Anti-IgE [EPC]Anti-IgE [EPC]Decreased IgE Activity [PE]
Packaging Options(4)
1 SYRINGE, GLASS in 1 CARTON (50242-227-01) / 2 mL in 1 SYRINGE, GLASS
1 SYRINGE, GLASS in 1 CARTON (50242-227-55) / 2 mL in 1 SYRINGE, GLASS
1 SYRINGE, GLASS in 1 CARTON (50242-227-86) / 2 mL in 1 SYRINGE, GLASS
1 SYRINGE, GLASS in 1 CARTON (50242-227-99) / 2 mL in 1 SYRINGE, GLASS